Ketamine-Assisted Therapy

Psychedelics biotech Awakn Life Sciences Corp. (OTCQB: AWKNF) announced the continuation of its Nordic expansion plans with a new 5-year lease for the opening of a clinic in the center of Trondheim. Awakn’s CEO Anthony Tennyson stated this is a “real momentum growing” for the...

A psychedelics R&D biotech company, known for providing novel treatments for addictions, is opening a new ketamine clinic.  Awakn Life Sciences Corp. (OTCQB: AWKNF) just signed a five-year lease in Oslo as part of the company’s Nordic expansion plans. Awakn’s new Norwegian...

(Part three of a four-part series) Have a look at previous stories: Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes Psychedelics And Treatment-Resistant Depression: Reactions On Published Results atai Life Sciences (NASDAQ: ATAI) and COMPASS...

Psychedelic medicine and telehealth provider TripSitter Clinic Ltd. has closed the acquisition of assets of Insight Systems PBC -aka Reconscious Medical-, a psychedelic psychotherapy company engaging in both in-clinic and online virtual care with safety, monitoring and support provided via a novel...

MY Self Wellness, a mental health and wellness center offering psychedelics-assisted therapy,  announced the launch of the nonprofit organization Warriors of Consciousness to help make ketamine treatments more affordable for those in need. The psychedelic treatment, which is not covered...

NYC-based clinics brand Nushama has partnered with Awakn Life Sciences (OTCQB: AWKNF), a clinical-stage psychedelics biotech company to bring Awakn’s advanced ketamine-assisted therapy treatment for AUD to Nushama’s New York clinics. They intend to provide sustained...

Senior health brand Irwin Naturals Inc. (OTC: IWINF) has entered into a binding agreement to acquire the assets of Clare Clinic Inc., d/b/a Florida Mind Health Center, operating three Florida healthcare clinics offering ketamine-assisted therapy, NAD+ and additional IV therapies.  The...

Psychedelics mental wellness telehealth company Nue Life Health PBC is now offering Nue Care, a personalized six-month aftercare program to treat the root causes of mental health disorders with personal sessions, progress tracking, health coaching, integration support and supplements towards...

PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs.  KETARX consists of hydrogel-forming...

Biotech psychedelics company Awakn Life Sciences Corp. (OTCQB: AWKNF) has just published its business and corporate updates. Besides researching, developing and commercializing therapeutics to treat substance and behavioral addictions, Awakn’s near-term focus is on the Alcohol Use...